Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (NVO)
NYSE:NVO
Novo Nordisk (NVO) Stock Price & Analysis
1,357 Followers
NVO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$94.48 - $172.97
Previous Close$157.85
Volume1.63M
Average Volume (3M)1.44M
Market Cap
kr2.40T
Enterprise Value$347.14B
Total Cash (Recent Filing)kr23.90B
Total Debt (Recent Filing)kr25.78B
Price to Earnings (P/E)41.6
Beta0.57
Next Earnings
Aug 10, 2023EPS Estimate
$1.28Last Dividend Ex-Date
Mar 24, 2023Dividend Yield
1.26 (0.79%)Share Statistics
EPS (TTM)3.80
Shares Outstanding1,720,000,000
10 Day Avg. Volume1,437,976
30 Day Avg. Volume1,444,778
Standard Deviation0.06
R-Squared0.18
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)9.27
Price to Sales (P/S)1.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$174.00Price Target Upside8.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Novo Nordisk News
Stock Analysis & IdeasLLY, DXCM, or ISRG: Which Healthcare Stock is the Top Stock Pick?
Stock Analysis & IdeasVGK: 5 Reasons I Like This European ETF
Pre-EarningsIs NVO a Buy, Before Earnings?
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NVO FAQ
What was Novo Nordisk’s price range in the past 12 months?
Novo Nordisk lowest stock price was $94.48 and its highest was $172.97 in the past 12 months.
What is Novo Nordisk’s market cap?
Currently, no data Available
When is Novo Nordisk’s upcoming earnings report date?
Novo Nordisk’s upcoming earnings report date is Aug 10, 2023 which is in 64 days.
How were Novo Nordisk’s earnings last quarter?
Novo Nordisk released its earnings results on May 04, 2023. The company reported $1.296 earnings per share for the quarter, beating the consensus estimate of $1.243 by $0.053.
Is Novo Nordisk overvalued?
According to Wall Street analysts Novo Nordisk’s price is currently Undervalued.
Does Novo Nordisk pay dividends?
Novo Nordisk pays a Semiannually dividend of $0.85 which represents an annual dividend yield of 0.8%. See more information on Novo Nordisk dividends here
What is Novo Nordisk’s EPS estimate?
Novo Nordisk’s EPS estimate is $1.28.
How many shares outstanding does Novo Nordisk have?
Novo Nordisk has 1,717,564,000 shares outstanding.
What happened to Novo Nordisk’s price movement after its last earnings report?
Novo Nordisk reported an EPS of $1.296 in its last earnings report, beating expectations of $1.243. Following the earnings report the stock price went down -4.375%.
Which hedge fund is a major shareholder of Novo Nordisk?
Among the largest hedge funds holding Novo Nordisk’s share is Fisher Asset Management LLC. It holds Novo Nordisk’s shares valued at 1B.
---
Novo Nordisk Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$174.00 (8.24% Upside)
$174.00 (8.24% Upside)
Blogger Sentiment
Bullish
NVO Sentiment 86%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.0%
Last 30 Days ▲ 6.5%
Last 30 Days ▲ 6.5%
News Sentiment
Very Positive
Bullish news 87%
Bearish news 13%
Bearish news 13%
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.70%
12-Months-Change
Fundamentals
Return on Equity
79.38%
Trailing 12-Months
Asset Growth
23.66%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Novo Nordisk
Novo Nordisk A/S is a Denmark-based healthcare company, which manufactures and markets pharmaceutical products globally. The company operates through two segments, including Diabetes & Obesity Care, and Biopharmaceuticals. The company was founded in 1925.
---
Top 5 ETFs holding NVO
VanEck Pharmaceutical ETF
$24.15M
Evolve Global Healthcare Enhanced Yield Fund Trust Units USD Unhedged
$13.68M
Evolve Global Healthcare Enhanced Yield Fund
$13.68M
Invesco International Dividend Achievers ETF
$9.63M
Brompton Global Healthcare Income & Growth ETF USD Trust Unit
$2.92M
Up to five ETFs with an Outperform Smart Score that hold NVO. The ETFs are listed according to market value of NVO within the ETF
---
---